Clinical Trial: Dapagliflozin and Right Heart Recovery After ASD Device Closure

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07823972) titled 'Dapagliflozin and Right Heart Recovery After ASD Device Closure' on Sept. 11.

Brief Summary: The aim of this study is to evaluate the clinical and echocardiographic influence of dapagliflozin on right ventricular reverse remodeling in adult patients following successful transcatheter Atrial Septal Defect (ASD) device closure.

Study Start Date: Nov. 01

Study Type: INTERVENTIONAL

Condition: ASD2(Secundum Atrial Septal Defect)

Intervention: DEVICE: trans catheter device closure

randomized clinical trila

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Nada Deyaa, ...